2022
DOI: 10.7759/cureus.27474
|View full text |Cite
|
Sign up to set email alerts
|

Anaesthetic Management in Mucopolysaccharidoses Patients: Clinical Experience in a Tertiary Hospital

Abstract: Introduction: Mucopolysaccharidoses (MPS) are a group of rare inherited metabolic diseases caused by the deficiency of enzymes required to degrade glycosaminoglycans (GAGs) in the lysosome with progressive and multiorgan involvement. Due to its progressive nature, a large number of patients need surgical intervention, which is associated with higher perioperative morbidity.Methods: We retrospectively reviewed 29 medical records regarding the peri and post-operative anaesthetic care of 10 children with mucopoly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…In contrast, the R group, solely administered with remimazolam, demonstrated longer induction and awakening times. This delay may stem from the slow onset and prolonged action duration of remimazolam, leading to an extended overall anesthesia period 21 , 22 . However, owing to its prolonged action, group R required fewer additional drugs during the operation.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, the R group, solely administered with remimazolam, demonstrated longer induction and awakening times. This delay may stem from the slow onset and prolonged action duration of remimazolam, leading to an extended overall anesthesia period 21 , 22 . However, owing to its prolonged action, group R required fewer additional drugs during the operation.…”
Section: Discussionmentioning
confidence: 99%